DE LA AGUILERA LUIS 4
4 · USCB FINANCIAL HOLDINGS, INC. · Filed May 15, 2026
Research Summary
AI-generated summary of this filing
USCB CEO Luis De La Aguilera Exercises Options and Sells Shares
What Happened
Luis De La Aguilera, President, CEO and Director of USCB Financial Holdings (USCB), exercised stock options and immediately sold all resulting shares across two days. On 2026-05-13 he exercised 19,947 options at $12.05 per share (cost $240,361) and sold those 19,947 shares in the open market at a weighted price of $18.06 for proceeds of $360,243. On 2026-05-14 he exercised 22,883 options at $12.05 per share (cost $275,740) and sold those 22,883 shares at a weighted price of $18.20 for proceeds of $416,471. Combined, he exercised 42,830 shares (total cost $516,101) and sold them for total proceeds of $776,714, a gross difference of about $260,613 before fees, taxes, or other costs. The filing also shows the corresponding derivative instruments (the options) were disposed ($0 reported) as part of the exercise/conversion.
Key Details
- Transaction dates: exercises sold on 2026-05-13 and 2026-05-14; Form 4 filed 2026-05-15 (timely within Form 4 reporting rules).
- Exercise price: $12.05 per share for both exercises.
- Sales: 5/13 sale weighted price $18.06 (sales ranged $18.00–$18.33 per F2); 5/14 sale weighted price $18.20 (sales ranged $18.10–$18.34 per F3).
- Totals: 42,830 shares exercised; total cost $516,101; total sale proceeds $776,714; gross proceeds minus exercise cost ≈ $260,613.
- Shares owned after transaction: not disclosed in the provided filing data.
- Notable footnotes: F1 describes existing restricted stock grants with multi-year vesting schedules; F4 notes the stock options vested one-third per year beginning Sept 27, 2022. F2 and F3 indicate the sale prices are weighted averages across multiple trades.
- Filing timeliness: Reported on 2026-05-15 for transactions on 5/13 and 5/14; appears to be filed within the required Form 4 timeframe.
Context
- This was an option exercise followed by immediate open-market sales (i.e., a cashless or sell-immediately transaction), which is common for executives exercising vested options to realize gains or cover tax/option costs.
- The derivative entries reported at $0 reflect the disposition/conversion of the option instruments upon exercise, not a separate gift or zero-cost sale.
- The filing is factual disclosure of transactions; it does not indicate the insider’s future views on the company.
Insider Transaction Report
- Exercise/Conversion
Class A Voting Common Stock
[F1]2026-05-13$12.05/sh+19,947$240,361→ 268,171 total - Sale
Class A Voting Common Stock
[F2][F1]2026-05-13$18.06/sh−19,947$360,243→ 242,945 total - Exercise/Conversion
Class A Voting Common Stock
[F1]2026-05-14$12.05/sh+22,883$275,740→ 265,828 total - Sale
Class A Voting Common Stock
[F3][F1]2026-05-14$18.20/sh−22,883$416,471→ 242,945 total - Exercise/Conversion
Stock Option (Right to Buy)
[F4]2026-05-13−19,947→ 134,774 totalExercise: $12.05From: 2022-09-27Exp: 2031-09-27→ Common Stock (19,947 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
[F4]2026-05-14−22,883→ 111,891 totalExercise: $12.05From: 2022-09-27Exp: 2031-09-27→ Common Stock (22,883 underlying)
Footnotes (4)
- [F1]Includes the grant of 27,632 shares of restricted stock which vest at a rate of one-third per year commencing on January 27, 2027, 17,102 shares of restricted stock from a grant of 25,653 shares which commenced vesting at a rate of one-third per year on January 21, 2026, 4,045 shares of restricted stock from a grant of 12,136 shares which commenced vesting at a rate of one-third per year on January 22, 2025, and 41,666 shares of restricted stock from a grant of 125,000 shares which commenced vesting at a rate of one-third per year on December 31, 2024.
- [F2]The price reported in column 4 is a weighted price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.33, inclusive. The reporting person undertakes to provide to USCB, or any security holder of USCB, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in column 4 is a weighted price. These shares were sold in multiple transactions at prices ranging from $18.10 to $18.34, inclusive. The reporting person undertakes to provide to USCB, or any security holder of USCB, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The stock options vested at the rate of one-third per year commencing on September 27, 2022.